scispace - formally typeset
S

Stéphanie Louis

Researcher at French Institute of Health and Medical Research

Publications -  12
Citations -  1216

Stéphanie Louis is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: IL-2 receptor & Antigen. The author has an hindex of 10, co-authored 12 publications receiving 1176 citations. Previous affiliations of Stéphanie Louis include University of Nantes & Centre national de la recherche scientifique.

Papers
More filters
Journal ArticleDOI

Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance.

TL;DR: Data show that chronic rejection is associated with a decrease in CD25hiCD4+T cells and FOXP3 transcripts, suggesting that clinically “operational tolerance” may be due to a maintained phenomenon of natural tolerance that is lacking in patients with chronic rejection.
Journal ArticleDOI

Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome.

TL;DR: It is shown that CR is associated with a decreased number of CD4+CD25highFOXP3+T cells with normal regulatory profile, whereas graft acceptance isassociated with CD4-CD25 highFOXP 3+T cell numbers similar to HVs, which suggest that Treg numbers, rather than their intrinsic suppressive capacity, may contribute to determining the long‐term fate of renal transplants.
Journal ArticleDOI

Phenotypically and Functionally Distinct CD8+ Lymphocyte Populations in Long-Term Drug-Free Tolerance and Chronic Rejection in Human Kidney Graft Recipients

TL;DR: Data show a strong cytotoxicity-associated CD8+CD28- signature in CR and suggest a suppression of pathologic cytot toxicity in DF-Tol, suggesting patients who are at risk for CR when immunosuppression is tapered are identified.
Journal ArticleDOI

Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation.

TL;DR: Comparison of T‐cell selection in drug‐free operationally tolerant kidney recipients (or with minimal immunosuppression), recipients with stable graft function, chronic rejection and healthy individuals is reported.